PRESS RELEASE published on 02/06/2024 at 14:01, 1 year 11 months ago MAINZ BIOMED ESTABLISHES PHYSICIAN-LED LABORATORY EXPANDING SERVICE OFFERING FOR PRIVATELY INSURED PATIENTS IN GERMANY Mainz Biomed N.V. (NASDAQ:MYNZ) has established the 'European Oncology Lab' (EOL), a physician-led laboratory for expanding service offering to privately insured patients in Germany. The lab will offer ColoAlert® as a laboratory medical service directly to physicians and patients, addressing the crucial requirement for invoicing private health insurance companies Germany Mainz Biomed N.V. European Oncology Lab ColoAlert Privately Insured Patients
PRESS RELEASE published on 11/09/2023 at 14:01, 2 years 2 months ago Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test
PRESS RELEASE published on 11/07/2023 at 14:01, 2 years 2 months ago Mainz Biomed to Showcase ColoAlert® at Leading Global Healthcare Event, MEDICA
PRESS RELEASE published on 10/31/2023 at 13:01, 2 years 3 months ago Mainz Biomed Reports Success from Employee Colorectal Cancer Screening Campaign in Partnership with Zöller-Kipper
PRESS RELEASE published on 10/26/2023 at 14:01, 2 years 3 months ago Mainz Biomed Appoints Tarrin Khairi-Taraki as VP of Commercial Operations
PRESS RELEASE published on 10/18/2023 at 14:01, 2 years 3 months ago Mainz Biomed Presents Groundbreaking Results of ColoFuture Study
PRESS RELEASE published on 10/11/2023 at 14:01, 2 years 3 months ago Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark
PRESS RELEASE published on 10/05/2023 at 14:01, 2 years 3 months ago Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit
PRESS RELEASE published on 10/04/2023 at 14:01, 2 years 3 months ago Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania
PRESS RELEASE published on 09/27/2023 at 14:01, 2 years 4 months ago Mainz Biomed to Present Detailed Results of ColoFuture Study at International Conference on Gastroenterology
Published on 02/03/2026 at 15:00, 1 hour 39 minutes ago Vox Royalty Announces Record 2025 Annual and Quarterly Receipts and Exceeds Annual Guidance
Published on 02/03/2026 at 14:29, 2 hours 10 minutes ago Worksport Ltd. Announces Strategic Partnership With Potomac International Partners to Accelerate Federal Government and Commercial Market Adoption of Clean Energy Ecosystem
Published on 02/03/2026 at 13:58, 2 hours 41 minutes ago QNX and Haleytek Join Forces to Deliver Software-Defined Audio for Volvo Cars' EX60 EV SUV
Published on 02/03/2026 at 13:30, 3 hours 9 minutes ago Alset AI's Lyken.AI Secures Cloud Compute Services Purchase Order from Leading Multinational Technology and Telecommunications Company
Published on 02/03/2026 at 13:30, 3 hours 9 minutes ago Lahontan Selects RESPEC and Kappes Cassiday to Update Santa Fe Mineral Resource Estimate and PEA
Published on 02/03/2026 at 16:05, 34 minutes ago Enjin Launches Essence of the Elements: A Cross-Game Multiverse Journey
Published on 02/03/2026 at 08:00, 8 hours 39 minutes ago EURAZEO & PANTHEON ESTABLISH A NEARLY €500 MILLION PRIVATE DEBT CONTINUATION VEHICLE
Published on 02/03/2026 at 08:00, 8 hours 39 minutes ago Neoen launches three new solar farms in France with a total capacity of 230 MWp
Published on 02/02/2026 at 18:23, 22 hours 16 minutes ago Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:00, 22 hours 39 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 17:35, 23 hours 4 minutes ago Disclosure of transactions in own shares from January 26 to January 30, 2026
